ReShape Lifesciences Inc (NASDAQ:RSLS) does about 1.65M shares in volume on a normal day but saw 2447680 shares change hands in the recent trading day. The company now has a market cap of 1.92M USD. Its current market price is $2.60, marking a decrease of -37.80% compared to the previous close of $4.18. The 52 week high reached by this stock is $414.99 whilst the lowest price level in 52 weeks is $4.03.
The consensus objective for the share price is $1450.00, suggesting that the stock has a potential upside of 99.82% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is -49.76%, -69.29%, and -97.17% away from its SMA20, SMA50, and SMA200 respectively, with the RSLS price moving above the 50-day SMA on current market day. ReShape Lifesciences Inc (RSLS) stock is down -39.68% over the week and -68.80% over the past month. Its price is -97.67% year-to-date and -99.30% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 99.82 percent from here.
Outstanding shares total 0.74M with insiders holding 1.39% of the shares and institutional holders owning 1.31% of the company’s common stock. The company has a return on investment of -278.38% and return on equity of -120.16%. The beta has a value of 1.29. Price to book ratio is 0.28 and price to sales ratio is 0.27.
